| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 1.349 | 6.523 | 12.233 | 15.646 |
| Total Income - EUR | - | - | - | - | - | - | 1.349 | 6.523 | 12.233 | 15.646 |
| Total Expenses - EUR | - | - | - | - | - | - | 3.174 | 10.059 | 17.285 | 19.699 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | -1.825 | -3.536 | -5.052 | -4.053 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | -1.865 | -3.732 | -5.052 | -4.053 |
| Employees | - | - | - | - | - | - | 1 | 1 | 1 | 0 |
Check the financial reports for the company - Evemavid S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 20 | 0 | 3.057 | 131 |
| Current Assets | - | - | - | - | - | - | 71 | 1.375 | 4.156 | 3.229 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 0 | 0 | 2.325 | 452 |
| Cash | - | - | - | - | - | - | 71 | 1.375 | 1.831 | 2.777 |
| Shareholders Funds | - | - | - | - | - | - | -1.825 | -5.562 | -10.597 | -14.591 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 1.916 | 6.937 | 17.810 | 17.958 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "3700 - 3700" | |||||||||
| CAEN Financial Year |
3700
|
|||||||||
Comments - Evemavid S.r.l.